---
type: "Gene_Or_Pathway"
description: "Caulobacter pathway substituting sphingolipids for lipid A"
sources: ["summaries/caulobacter_fur_lipida_loss__REPORT.md"]
---
# Caulobacter sphingolipid biosynthesis

## What this entity is

**Canonical name:** Caulobacter sphingolipid biosynthesis.  
**Known aliases:** Caulobacter sphingolipid substitute pathway; sphingolipid biosynthesis pathway.  
**Stable external identifier:** No stable pathway identifier was reported in the source document. [src: caulobacter_fur_lipida_loss]

This pathway is a Caulobacter-specific lipid A-substitution route associated with [[entities/caulobacter-crescentus]] and the rescued Δ*fur* Δ*sspB* Δ*lpxc* state. [src: caulobacter_fur_lipida_loss]

## Key facts

The pathway was constitutive rather than induced in the tested rescue state: 0/6 sphingolipid-biosynthesis genes were UP. [src: caulobacter_fur_lipida_loss]

The *spt* transcript was DOWN by -0.64 logFC with FDR 0.002, and *sphk* was DOWN by -0.40 logFC with FDR 0.02. [src: caulobacter_fur_lipida_loss]

These results support the interpretation that sphingolipid biosynthesis was already present as a substitute pathway rather than being transcriptionally induced during the measured rescue response. [src: caulobacter_fur_lipida_loss]

Comparative NCBI annotation found that *spt* and *cerR* were Caulobacter-unique across *C. crescentus*, *Acinetobacter baumannii*, *Neisseria meningitidis*, and *Moraxella catarrhalis*, with pattern 1000. [src: caulobacter_fur_lipida_loss]

The comparator species therefore lacked the Caulobacter sphingolipid-substitution pathway in the tested annotation comparison. [src: caulobacter_fur_lipida_loss]

The sphingolipid transporter CCNA_01226, also called *lptC2*, had transcript logFC -0.60 with FDR 0.034, while its protein changed by +1.08 log2 in 4672/4659. [src: caulobacter_fur_lipida_loss]

Because CCNA_01226 protein was already DOWN by -0.42 log2 in 4659/4580, its net protein change versus the wild-type baseline was +0.66 log2, reported as approximately 1.58×. [src: caulobacter_fur_lipida_loss]

The CCNA_01226 transcript–protein discordance is consistent with post-transcriptional stabilization of sphingolipid-transport machinery, but the single-replicate proteomics does not establish this statistically. [src: caulobacter_fur_lipida_loss]

## Interpretation and limitations

The pathway finding strengthens the model in which [[entities/lpxc]] loss is tolerated through replacement of outer-leaflet lipid A by sphingolipid-associated membrane architecture, rather than through induction of sphingolipid biosynthesis during the rescue state. [src: caulobacter_fur_lipida_loss]

The source did not report replicated proteomics or lipidomics sufficient to determine whether sphingolipid abundance or transport flux changed in the rescue state. [src: caulobacter_fur_lipida_loss]

Targeted *lptC2* assays, replicated outer-membrane proteomics, and lipidomics are needed to test whether the observed transporter-level changes reflect functional sphingolipid remodeling. [src: caulobacter_fur_lipida_loss]

## Related pages

- [[summaries/caulobacter_fur_lipida_loss__REPORT]] — source summary containing the pathway, transporter, and comparative-annotation findings.
- [[concepts/multi-omics-integration]] — integrates transcript, proteome, fitness, regulon, and comparative-annotation evidence from the project.
- [[concepts/gene-essentiality]] — places the lipid A-loss rescue state in the context of condition-dependent viability.
- [[entities/caulobacter-crescentus]] — organism in which the pathway was analyzed.
- [[entities/lpxc]] — lipid A-biosynthesis component whose deletion defines the rescue phenotype.
